Business Standard

Divis Laboratories' Q3 net profit rises 69% to Rs 379.49 cr; revenue up 30%

Divis Labs had reported a net profit of Rs 397.65 crore on total revenue of Rs 1,365 crore in the quarter ended September 2018

q3, result, quarter
Premium

Photo: Shutterstock

BS Reporter Hyderabad
Hyderabad-based active pharmaceutical ingredients (APIs) and drug intermediates' maker Divis Laboratories Limited has reported a 68.9 per cent increase in net profit at Rs 379.49 crore for the quarter ended December 2018 as compared to Rs 224.66 crore in the corresponding quarter of the previous year.

Total revenue grew 30.58 per cent to Rs 1,377.48 crore during the quarter under review as compared to Rs 1,054.89 crore in the year-ago period.

Big increase in net profit comes on the back of higher growth in revenue and the profit margins as compared to its performance in corresponding period of the previous quarter.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in